1. The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR.
- Author
-
Betsou, Afrodite, Lambropoulou, Maria, Georgakopoulou, Anastasia-Eirini, Kostomitsopoulos, Nikolaos, Konstandi, Ourania, Anagnostopoulos, Konstantinos, Tsalikidis, Christos, Simopoulos, Constantinos E., Valsami, Georgia, and Tsaroucha, Alexandra K.
- Subjects
REPERFUSION ,ANIMAL disease models ,MYOCARDIAL reperfusion ,MATRIX metalloproteinases ,SILIBININ ,LIVER proteins ,LABORATORY rats - Abstract
Objectives We investigated the positive effect of silibinin after IV administration as silibininhydroxypropyl-ß-cyclodextrin lyophilized product, by measuring gene expression and liver tissue protein levels of tumor necrosis factor-a, interleukin-6, monocyte chemoattractant protein-1, matrix metalloproteinases matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases-2. Methods 63 Wistar rats of age 13.24±4.40 weeks underwent ischemia/reperfusion (I/R) injury of the liver. The animals were randomized into three groups: Sham (S; n = 7); Control (C; n-28); silibinin (Si; n-28). The C and Si groups underwent 45 min ischemia. Si received silibinin-hydroxypropyl-ß-cyclodextrin intravenously immediately before reperfusion at a dose of 5 mg/kg. Both groups were further divided into 4 subgroups, based on euthanasia time (i.e., 60, 120, 180 and 240 min). Key findings qRT-PCR results confirmed the statistically significant reduction of the expression of the pro-inflammatory factors at 240 min after I/R injury (tumor necrosis factor-a: P < 0.05; MCR1: P < 0.05) and matrix metalloproteinases (matrix metalloproteinases 2: P < 0.05; matrix metalloproteinases 3: P < 0.05) and the increase of tissue inhibitor of matrix metalloproteinases-2 in liver tissue in the Si group. Moreover, results of immunohistochemistry levels confirmed that at 240 min pro-inflammatory factors (tumor necrosis factor-a: P < 0.05; MCR1: P < 0.05) and matrix metalloproteinases (matrix metalloproteinases 2: P < 0.05; matrix metalloproteinases 3: P < 0.05) had a statistically significantly lower expression in the Si group while tissue inhibitor of matrix metalloproteinases-2 had a higher expression. Conclusions Silibinin may have a beneficial effect on the protection of the liver. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF